QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019

Background: Observational studies have suggested increased arrhythmic and cardiovascular risk with the combination use of hydroxychloroquine (HCQ) and azithromycin in patients with coronavirus disease 2019 (COVID-19). Objective: The arrhythmic safety profile of HCQ monotherapy, which remains under i...

Full description

Bibliographic Details
Main Authors:	Arun R. Sridhar, MBBS, MPH, Neal A. Chatterjee, MD, MSc, Basil Saour, MD, Dan Nguyen, MD, Elizabeth A. Starnes, ARNP, Christine Johnston, MD, MPH, Margaret L. Green, MD, MPH, Gregory A. Roth, MD, Jeanne E. Poole, MD, FHRS
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	Heart Rhythm O2
Subjects:	Coronavirus Electrocardiogram Hydroxychloroquine QT interval Ventricular arrhythmia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666501820300751

Similar Items

Effects of Cardiac Resynchronization Therapy on the Arrhythmic Substrate in a Patient with Long QT and Torsades de pointes
by: Masayasu Ikutomi, MD, et al.
Published: (2011-01-01)

Electrocardiogram of a patient on COVID-19 treatment
by: Amal El Ouarradi, et al.
Published: (2020-04-01)

HCQ induced QT prolongation- Primum non nocere
by: A.J. Mahendran, et al.
Published: (2020-09-01)

Hydroxychloroquine and azithromycin use in COVID-19 era and cardiovascular concerns: Current perspective
by: Aditya Kapoor, et al.
Published: (2021-01-01)

Proarrhythmia assessment in treatment with hydroxychloroquine and azithromycin hospitalized elderly COVID-19 patients - our experience
by: Raffaele Costa, et al.
Published: (2021-06-01)

Hydroxychloroquine-associated pigmentation after extravasation injury
by: Keunyoung Hur, MD, et al.
Published: (2021-06-01)

Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan
by: Kazimieras Maneikis, et al.
Published: (2021-02-01)

Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases
by: Yanting Yu, et al.
Published: (2021-04-01)

Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine
by: Grace A. Hile, BS, et al.
Published: (2017-07-01)

Congenital long QT syndrome: A difficult journey for one young survivor
by: Elizabeth V. Saarel, MD, FHRS, et al.
Published: (2015-11-01)

Primary cutaneous low-grade B-cell lymphoma treated with hydroxychloroquine
by: Megan Lim, MD, et al.
Published: (2020-10-01)

Longitudinal melanonychia and skin hyperpigmentation associated with hydroxychloroquine therapy
by: Jose W. Ricardo, MD, et al.
Published: (2021-01-01)

Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
by: Mohammad Munshi, MD, et al.
Published: (2020-07-01)

Normalization of QT interval duration in a long QT syndrome patient during pregnancy and the postpartum period due to sex hormone effects on cardiac repolarization
by: Katja E. Odening, MD, et al.
Published: (2016-05-01)

The QT Intervals in Infancy and Time for Infantile ECG Screening for Long QT Syndrome
by: Masao Yoshinaga, MD PhD, et al.
Published: (2011-01-01)

Cardiovascular safety of hydroxychloroquine: Brief appraisal of data
by: Anil Pareek, et al.
Published: (2021-01-01)

Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
by: Hülya Gamze Çelik, et al.
Published: (2021-01-01)

Prolongamento do intervalo QT do eletrocardiograma em pacientes reumáticos usando antimaláricos ECG QT interval prolongation in rheumatic patients using antimalarial drugs
by: Ludmilla Daru Rey, et al.
Published: (2003-10-01)

Prolonged QT Interval in SARS-CoV-2 Infection: Prevalence and Prognosis
by: Núria Farré, et al.
Published: (2020-08-01)

Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
by: Usha Yendrapalli, et al.
Published: (2021-11-01)

DESARROLLO PROGRESIVO DE ONDA J GIGANTE Y PROLONGACIÓN EXTREMA DEL INTERVALO QT EN LA HIPOTERMIA INDUCIDA / Progressive development of giant J wave and extreme prolongation of QT interval in induced hypothermia
by: Yaniel Castro Torres, et al.
Published: (2013-07-01)

The congenital long QT syndrome Type 3: An update
by: Andrés Ricardo Pérez-Riera, et al.
Published: (2018-01-01)

Managing QT prolongation in the Era of Coronavirus Disease 2019 (COVID-19)
by: sidhi laksono purwowiyoto
Published: (2020-05-01)

Dexamethasone suppresses long QT phenotype in patient with acute promyelocytic leukemia treated with arsenic
by: Jeffrey R. Winterfield, MD, FHRS, et al.
Published: (2016-07-01)

The diagnosis and management of long QT syndrome based on fetal echocardiography
by: Benjamin A. Blais, MD, et al.
Published: (2017-09-01)

A Pilot Study to Examine the Feasibility of Measuring the QT Interval at Community Health Fairs
by: Gallo, Tyler, et al.
Published: (2016)

Prognostic value of QT interval prolongation in patients with acute ischemic stroke
by: Iranmanesh F (MD), et al.
Published: (2012-12-01)

Prevalence and QT Interval of Early Repolarization in a Hospital-based Population
by: Hideki Hayashi, MD PhD, et al.
Published: (2010-01-01)

Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
by: Hirotaro Sugiyama, MD, et al.
Published: (2017-06-01)

Detecting Restenosis after Percutaneous Coronary Intervention Using Exercise-Stress Electrocardiogram Findings Including QT Dispersion
by: Bonpei Takase, MD, et al.
Published: (2006-01-01)

The relationship between QT interval indices with cardiac autonomic neuropathy in diabetic patients: a case control study
by: Maryam Vasheghani, et al.
Published: (2020-11-01)

Aborted Sudden Cardiac Death Associated with Short QT Syndrome
by: Kaoru Okishige, MD, et al.
Published: (2009-01-01)

Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations
by: Ilija Uzelac, PhD, MBA, et al.
Published: (2021-08-01)

Familial long QT syndrome and late development of dilated cardiomyopathy in a child with a KCNQ1 mutation: A case report
by: Kiona Y. Allen, MD, et al.
Published: (2016-03-01)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
by: Okayasu H, et al.
Published: (2021-01-01)

Ulcerative necrobiosis lipoidica in the setting of anti–tumor necrosis factor-α and hydroxychloroquine treatment for rheumatoid arthritis
by: Jennifer Albus Fehlman, MD, et al.
Published: (2017-03-01)

Síndrome de QT prolongado congénito y embarazo: reporte de dos casos
by: Julián M. Aristizábal, MD, et al.
Published: (2010-03-01)

A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation
by: Anand Prakash Singh, et al.
Published: (2020-06-01)

Postural Change-associated Alterations in QT/QTc Intervals on Electrocardiograms
by: Yutaka Kubo, MD, et al.
Published: (2005-01-01)

Complexity of ranolazine and phenytoin use in an infant with long QT syndrome type 3
by: Reina Bianca Tan, MD, et al.
Published: (2017-01-01)